Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1153 to 1162 of 1162 entries
Sorted by: Best Match Show Resources per page
Access to Care: End-to-End Digital Response for Covid-19 Care Delivery.

The journal for nurse practitioners : JNP

Cooling M, Klein CJ, Pierce L, Delinski N, Lotz A, Vozenilek JA.
PMID: 34608377
J Nurse Pract. 2021 Sep 25; doi: 10.1016/j.nurpra.2021.09.011. Epub 2021 Sep 25.

The coronavirus disease 2019 pandemic disrupted healthcare, requiring organizational leaders to act quickly to manage the health-related concerns of individuals and communities. The ability to offer a variety of digitally enabled telehealth services with 24/7 access to nurse practitioners...

Cite
Cooling M, Klein CJ, Pierce L, et al. Access to Care: End-to-End Digital Response for Covid-19 Care Delivery. J Nurse Pract. 2021;doi: 10.1016/j.nurpra.2021.09.011.
Cooling, M., Klein, C. J., Pierce, L., Delinski, N., Lotz, A., & Vozenilek, J. A. (2021). Access to Care: End-to-End Digital Response for Covid-19 Care Delivery. The journal for nurse practitioners : JNP, . https://doi.org/10.1016/j.nurpra.2021.09.011
Cooling, Melinda, et al. "Access to Care: End-to-End Digital Response for Covid-19 Care Delivery." The journal for nurse practitioners : JNP vol. (2021). doi: https://doi.org/10.1016/j.nurpra.2021.09.011
Cooling M, Klein CJ, Pierce L, Delinski N, Lotz A, Vozenilek JA. Access to Care: End-to-End Digital Response for Covid-19 Care Delivery. J Nurse Pract. 2021 Sep 25; doi: 10.1016/j.nurpra.2021.09.011. Epub 2021 Sep 25. PMID: 34608377; PMCID: PMC8482474.
Copy Download .nbib Format: NLM
Association Between Ionized Calcium Level and Neurological Outcome in Endovascularly Treated Patients with Spontaneous Subarachnoid Hemorrhage: A Retrospective Cohort Study.

Neurocritical care

Epstein D, Freund Y, Marcusohn E, Diab T, Klein E, Raz A, Neuberger A, Miller A.
PMID: 33829378
Neurocrit Care. 2021 Dec;35(3):723-737. doi: 10.1007/s12028-021-01214-3. Epub 2021 Apr 07.

BACKGROUND: Spontaneous subarachnoid hemorrhage (SSAH) is associated with significant morbidity and mortality. Pathophysiological processes following initial bleeding are complex and not fully understood. In this study, we aimed to determine whether a low level of ionized calcium (CaMETHODS: This...

Cite
Epstein D, Freund Y, Marcusohn E, et al. Association Between Ionized Calcium Level and Neurological Outcome in Endovascularly Treated Patients with Spontaneous Subarachnoid Hemorrhage: A Retrospective Cohort Study. Neurocrit Care. 2021;35(3):723-737doi: 10.1007/s12028-021-01214-3.
Epstein, D., Freund, Y., Marcusohn, E., Diab, T., Klein, E., Raz, A., Neuberger, A., & Miller, A. (2021). Association Between Ionized Calcium Level and Neurological Outcome in Endovascularly Treated Patients with Spontaneous Subarachnoid Hemorrhage: A Retrospective Cohort Study. Neurocritical care, 35(3), 723-737. https://doi.org/10.1007/s12028-021-01214-3
Epstein, Danny, et al. "Association Between Ionized Calcium Level and Neurological Outcome in Endovascularly Treated Patients with Spontaneous Subarachnoid Hemorrhage: A Retrospective Cohort Study." Neurocritical care vol. 35,3 (2021): 723-737. doi: https://doi.org/10.1007/s12028-021-01214-3
Epstein D, Freund Y, Marcusohn E, Diab T, Klein E, Raz A, Neuberger A, Miller A. Association Between Ionized Calcium Level and Neurological Outcome in Endovascularly Treated Patients with Spontaneous Subarachnoid Hemorrhage: A Retrospective Cohort Study. Neurocrit Care. 2021 Dec;35(3):723-737. doi: 10.1007/s12028-021-01214-3. Epub 2021 Apr 07. PMID: 33829378.
Copy Download .nbib Format: NLM
Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.

Neurology

Shelly S, Klein CJ, Dyck PJB, Paul P, Mauermann ML, Berini SE, Howe B, Fryer JP, Basal E, Bakri HM, Laughlin RS, McKeon A, Pittock SJ, Mills J, Dubey D.
PMID: 34635556
Neurology. 2021 Dec 14;97(24):e2392-e2403. doi: 10.1212/WNL.0000000000012932. Epub 2021 Oct 11.

BACKGROUND AND OBJECTIVE: Multiple studies highlighting the diagnostic utility of neurofascin-155 (NF155)-immunoglobulin G4 (IgG4) in chronic demyelinating inflammatory polyradiculoneuropathy (CIDP) have been published. However, few studies comprehensively address the long-term outcomes or clinical utility of NF155-immunoglobulin M (IgM) or...

Cite
Shelly S, Klein CJ, Dyck PJB, et al. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology. 2021;97(24):e2392-e2403doi: 10.1212/WNL.0000000000012932.
Shelly, S., Klein, C. J., Dyck, P. J. B., Paul, P., Mauermann, M. L., Berini, S. E., Howe, B., Fryer, J. P., Basal, E., Bakri, H. M., Laughlin, R. S., McKeon, A., Pittock, S. J., Mills, J., & Dubey, D. (2021). Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology, 97(24), e2392-e2403. https://doi.org/10.1212/WNL.0000000000012932
Shelly, Shahar, et al. "Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes." Neurology vol. 97,24 (2021): e2392-e2403. doi: https://doi.org/10.1212/WNL.0000000000012932
Shelly S, Klein CJ, Dyck PJB, Paul P, Mauermann ML, Berini SE, Howe B, Fryer JP, Basal E, Bakri HM, Laughlin RS, McKeon A, Pittock SJ, Mills J, Dubey D. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology. 2021 Dec 14;97(24):e2392-e2403. doi: 10.1212/WNL.0000000000012932. Epub 2021 Oct 11. PMID: 34635556; PMCID: PMC8673722.
Copy Download .nbib Format: NLM
Flexible, Self-Supported Anode for Organic Batteries with a Matched Hierarchical Current Collector System for Boosted Current Density.

Small (Weinheim an der Bergstrasse, Germany)

Beladi-Mousavi SM, Klein J, Ciobanu M, Sadaf S, Mahmood AM, Walder L.
PMID: 34647677
Small. 2021 Dec;17(50):e2103885. doi: 10.1002/smll.202103885. Epub 2021 Oct 14.

The inherent flexibility of redox-active organic polymers and carbon-based fillers, combined with flexible current collectors (CCs) is ideal for the fabrication of flexible batteries. Herein, a one-step electrophoretic deposition of polyviologen (PV)/graphene-oxide (GO) aqueous composites onto a flexible mesh...

Cite
Beladi-Mousavi SM, Klein J, Ciobanu M, et al. Flexible, Self-Supported Anode for Organic Batteries with a Matched Hierarchical Current Collector System for Boosted Current Density. Small. 2021;17(50):e2103885doi: 10.1002/smll.202103885.
Beladi-Mousavi, S. M., Klein, J., Ciobanu, M., Sadaf, S., Mahmood, A. M., & Walder, L. (2021). Flexible, Self-Supported Anode for Organic Batteries with a Matched Hierarchical Current Collector System for Boosted Current Density. Small (Weinheim an der Bergstrasse, Germany), 17(50), e2103885. https://doi.org/10.1002/smll.202103885
Beladi-Mousavi, Seyyed Mohsen, et al. "Flexible, Self-Supported Anode for Organic Batteries with a Matched Hierarchical Current Collector System for Boosted Current Density." Small (Weinheim an der Bergstrasse, Germany) vol. 17,50 (2021): e2103885. doi: https://doi.org/10.1002/smll.202103885
Beladi-Mousavi SM, Klein J, Ciobanu M, Sadaf S, Mahmood AM, Walder L. Flexible, Self-Supported Anode for Organic Batteries with a Matched Hierarchical Current Collector System for Boosted Current Density. Small. 2021 Dec;17(50):e2103885. doi: 10.1002/smll.202103885. Epub 2021 Oct 14. PMID: 34647677.
Copy Download .nbib Format: NLM
Patterns of tau pathology identified with .

Alzheimer's & dementia : the journal of the Alzheimer's Association

Kreisl WC, Lao PJ, Johnson A, Tomljanovic Z, Klein J, Polly K, Maas B, Laing KK, Chesebro AG, Igwe K, Razlighi QR, Honig LS, Yan X, Lee S, Mintz A, Luchsinger JA, Stern Y, Devanand DP, Brickman AM.
PMID: 34057284
Alzheimers Dement. 2021 May 31; doi: 10.1002/alz.12384. Epub 2021 May 31.

No abstract available.

Cite
Kreisl WC, Lao PJ, Johnson A, et al. Patterns of tau pathology identified with . Alzheimers Dement. 2021;doi: 10.1002/alz.12384.
Kreisl, W. C., Lao, P. J., Johnson, A., Tomljanovic, Z., Klein, J., Polly, K., Maas, B., Laing, K. K., Chesebro, A. G., Igwe, K., Razlighi, Q. R., Honig, L. S., Yan, X., Lee, S., Mintz, A., Luchsinger, J. A., Stern, Y., Devanand, D. P., & Brickman, A. M. (2021). Patterns of tau pathology identified with . Alzheimer's & dementia : the journal of the Alzheimer's Association, . https://doi.org/10.1002/alz.12384
Kreisl, William Charles, et al. "Patterns of tau pathology identified with ." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. (2021). doi: https://doi.org/10.1002/alz.12384
Kreisl WC, Lao PJ, Johnson A, Tomljanovic Z, Klein J, Polly K, Maas B, Laing KK, Chesebro AG, Igwe K, Razlighi QR, Honig LS, Yan X, Lee S, Mintz A, Luchsinger JA, Stern Y, Devanand DP, Brickman AM. Patterns of tau pathology identified with . Alzheimers Dement. 2021 May 31; doi: 10.1002/alz.12384. Epub 2021 May 31. PMID: 34057284; PMCID: PMC8630090.
Copy Download .nbib Format: NLM
Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels.

Neurology

Shelly S, Mills JR, Dubey D, McKeon A, Zekeridou A, Pittock SJ, Harper CM, Naddaf E, Milone M, Mandrekar J, Klein CJ.
PMID: 33903199
Neurology. 2021 Apr 26; doi: 10.1212/WNL.0000000000012050. Epub 2021 Apr 26.

OBJECTIVE: To critically assess the clinical utility of striational antibodies (StrAbs) within paraneoplastic and myasthenia gravis serological evaluations.METHODS: All Mayo Clinic patients tested for StrAbs from January 1RESULTS: 38,502 unique paraneoplastic and 1,899 MG patients were tested. In paraneoplastic...

Cite
Shelly S, Mills JR, Dubey D, et al. Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels. Neurology. 2021;doi: 10.1212/WNL.0000000000012050.
Shelly, S., Mills, J. R., Dubey, D., McKeon, A., Zekeridou, A., Pittock, S. J., Harper, C. M., Naddaf, E., Milone, M., Mandrekar, J., & Klein, C. J. (2021). Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels. Neurology, . https://doi.org/10.1212/WNL.0000000000012050
Shelly, Shahar, et al. "Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels." Neurology vol. (2021). doi: https://doi.org/10.1212/WNL.0000000000012050
Shelly S, Mills JR, Dubey D, McKeon A, Zekeridou A, Pittock SJ, Harper CM, Naddaf E, Milone M, Mandrekar J, Klein CJ. Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels. Neurology. 2021 Apr 26; doi: 10.1212/WNL.0000000000012050. Epub 2021 Apr 26. PMID: 33903199.
Copy Download .nbib Format: NLM
Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy.

JACC. Case reports

Klein EC, Rubinstein J, Strande JL.
PMID: 34316787
JACC Case Rep. 2019 Aug 21;1(2):213-217. doi: 10.1016/j.jaccas.2019.07.008. eCollection 2019 Aug.

A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy. Given his wishes to die without having any intravenous medications, he was started on oral...

Cite
Klein EC, Rubinstein J, Strande JL. Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy. JACC Case Rep. 2019;1(2):213-217doi: 10.1016/j.jaccas.2019.07.008.
Klein, E. C., Rubinstein, J., & Strande, J. L. (2019). Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy. JACC. Case reports, 1(2), 213-217. https://doi.org/10.1016/j.jaccas.2019.07.008
Klein, Evan C, et al. "Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy." JACC. Case reports vol. 1,2 (2019): 213-217. doi: https://doi.org/10.1016/j.jaccas.2019.07.008
Klein EC, Rubinstein J, Strande JL. Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy. JACC Case Rep. 2019 Aug 21;1(2):213-217. doi: 10.1016/j.jaccas.2019.07.008. eCollection 2019 Aug. PMID: 34316787; PMCID: PMC8301499.
Copy Download .nbib Format: NLM
ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures.

Annals of surgical oncology

Bleicher RJ, Moran MS, Ruth K, Edge SB, Dietz JM, Wilke LG, Stearns V, Kurtzman SH, Klein J, Yao KA.
PMID: 34346019
Ann Surg Oncol. 2021 Dec;28:572-573. doi: 10.1245/s10434-021-10535-8.

No abstract available.

Cite
Bleicher RJ, Moran MS, Ruth K, et al. ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Ann Surg Oncol. 2021;28:572-573doi: 10.1245/s10434-021-10535-8.
Bleicher, R. J., Moran, M. S., Ruth, K., Edge, S. B., Dietz, J. M., Wilke, L. G., Stearns, V., Kurtzman, S. H., Klein, J., & Yao, K. A. (2021). ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Annals of surgical oncology, 28572-573. https://doi.org/10.1245/s10434-021-10535-8
Bleicher, Richard J, et al. "ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures." Annals of surgical oncology vol. 28 (2021): 572-573. doi: https://doi.org/10.1245/s10434-021-10535-8
Bleicher RJ, Moran MS, Ruth K, Edge SB, Dietz JM, Wilke LG, Stearns V, Kurtzman SH, Klein J, Yao KA. ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Ann Surg Oncol. 2021 Dec;28:572-573. doi: 10.1245/s10434-021-10535-8. PMID: 34346019.
Copy Download .nbib Format: NLM
Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study.

CJEM

Davis AL, Sunderji A, Marneni SR, Seiler M, Hall JE, Cotanda CP, Klein EJ, Brown JC, Gelernter R, Griffiths MA, Hoeffe J, Gualco G, Mater A, Manzano S, Thompson GC, Ahmed S, Ali S, Goldman RD.
PMID: 34402036
CJEM. 2021 Nov;23(6):778-786. doi: 10.1007/s43678-021-00174-z. Epub 2021 Aug 16.

OBJECTIVE: To determine if caregivers of children presenting to pediatric emergency departments (EDs) during the COVID-19 pandemic are delaying presenting to care for fear of contracting COVID-19.METHODS: This was a pre-planned secondary analysis of a cross-sectional survey study of...

Cite
Davis AL, Sunderji A, Marneni SR, et al. Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study. CJEM. 2021;23(6):778-786doi: 10.1007/s43678-021-00174-z.
Davis, A. L., Sunderji, A., Marneni, S. R., Seiler, M., Hall, J. E., Cotanda, C. P., Klein, E. J., Brown, J. C., Gelernter, R., Griffiths, M. A., Hoeffe, J., Gualco, G., Mater, A., Manzano, S., Thompson, G. C., Ahmed, S., Ali, S., Goldman, R. D. (2021). Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study. CJEM, 23(6), 778-786. https://doi.org/10.1007/s43678-021-00174-z
Davis, Adrienne L, et al. "Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study." CJEM vol. 23,6 (2021): 778-786. doi: https://doi.org/10.1007/s43678-021-00174-z
Davis AL, Sunderji A, Marneni SR, Seiler M, Hall JE, Cotanda CP, Klein EJ, Brown JC, Gelernter R, Griffiths MA, Hoeffe J, Gualco G, Mater A, Manzano S, Thompson GC, Ahmed S, Ali S, Goldman RD. Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study. CJEM. 2021 Nov;23(6):778-786. doi: 10.1007/s43678-021-00174-z. Epub 2021 Aug 16. PMID: 34402036; PMCID: PMC8366744.
Copy Download .nbib Format: NLM
Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF).

Scars, burns & healing

Waldner M, Ismail T, Lunger A, Klein HJ, Schweizer R, Alan O, Breckwoldt T, Giovanoli P, Plock JA.
PMID: 35024172
Scars Burn Heal. 2022 Jan 06;8:20595131211052394. doi: 10.1177/20595131211052394. eCollection 2022.

BACKGROUND: Deep partial-thickness burns are traditionally treated by tangential excision and split thickness skin graft (STSG) coverage. STSGs create donor site morbidity and increase the wound surface in burn patients. Herein, we present a novel concept consisting of enzymatic...

Cite
Waldner M, Ismail T, Lunger A, et al. Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF). Scars Burn Heal. 2022;8:20595131211052394doi: 10.1177/20595131211052394.
Waldner, M., Ismail, T., Lunger, A., Klein, H. J., Schweizer, R., Alan, O., Breckwoldt, T., Giovanoli, P., & Plock, J. A. (2022). Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF). Scars, burns & healing, 820595131211052394. https://doi.org/10.1177/20595131211052394
Waldner, Matthias, et al. "Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF)." Scars, burns & healing vol. 8 (2022): 20595131211052394. doi: https://doi.org/10.1177/20595131211052394
Waldner M, Ismail T, Lunger A, Klein HJ, Schweizer R, Alan O, Breckwoldt T, Giovanoli P, Plock JA. Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF). Scars Burn Heal. 2022 Jan 06;8:20595131211052394. doi: 10.1177/20595131211052394. eCollection 2022. PMID: 35024172; PMCID: PMC8743980.
Copy Download .nbib Format: NLM
Showing 1153 to 1162 of 1162 entries